AGF US Market Neutral Anti-Beta Fund
BTAL
80 hedge funds and large institutions have $217M invested in AGF US Market Neutral Anti-Beta Fund in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 20 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
13% more funds holding
Funds holding: 71 → 80 (+9)
9.08% more ownership
Funds ownership: 68.48% → 77.56% (+9.1%)
21% less capital invested
Capital invested by funds: $276M → $217M (-$59.1M)
27% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$37.9M |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$7.54M |
| 3 |
WIA
Wealthedge Investment Advisors
New York
|
+$2.4M |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$1.27M |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
-$18.3M |
| 2 |
Jane Street
New York
|
-$14.6M |
| 3 |
Morgan Stanley
New York
|
-$12.6M |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$7.06M |
| 5 |
FGA
Fortis Group Advisors
Westwood,
New Jersey
|
-$6.42M |
BTAL Hedge Fund Activity: Q2 2025 in Review
80 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q2 2025, worth a combined $217M — down 21% from $276M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BTAL positions and 20 closed out — a net gain of 9 holders — while 19 added to existing stakes and 26 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $37.9M. The largest seller was Kovitz Investment Group Partners, cutting an estimated $18.3M.
- 80 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q2 2025, up from 71 in Q1 2025.
- Funds reported $217M of AGF US Market Neutral Anti-Beta Fund stock for Q2 2025, down 21% quarter-over-quarter.
- 29 funds opened new AGF US Market Neutral Anti-Beta Fund positions in Q2 2025 and 20 closed out, a net change of +9 holders.
- The largest AGF US Market Neutral Anti-Beta Fund buyer in Q2 2025 was Fidelity Investments, an estimated $37.9M added.
- The largest AGF US Market Neutral Anti-Beta Fund seller in Q2 2025 was Kovitz Investment Group Partners, an estimated $18.3M sold.
Based on aggregated 13F filings for Q2 2025.